Literature DB >> 25876051

Association between the ACE gene I/D polymorphism and osteoporosis in a Turkish population.

B Cakmak1, A Inanir, N Karakus, O Ates, S Yigit.   

Abstract

PURPOSE: The purpose of this study was to assess the relationship between osteoporosis and the angiotensin-converting enzyme (ACE) gene insertion/deletion (I/D) polymorphism in a Turkish population.
METHODS: The study group consisted of 238 unrelated women with osteoporosis and 124 unrelated healthy female controls. All participants, patients and healthy controls, were of Turkish origin from the central region of Turkey. Genomic DNA was isolated from whole venous blood samples using a commercial DNA isolation kit. The ACE gene I/D polymorphism was analysed by polymerase chain reaction and gel electrophoresis.
RESULTS: Frequencies of the DD, ID and II genotypes in the patients were 44.5, 41.2 and 14.3 %, and in the controls they were 25.0, 51.6 and 23.4 %, respectively. A significant difference was observed between patients and controls according to genotype frequency (p=0.001). D and I allele frequencies of the I/D polymorphism were 65.1 and 34.9 % in the patient group and 50.8 and 49.2 % in the control group, respectively (p<0.001).
CONCLUSION: The ACE gene I/D polymorphism could be a genetic factor associated with osteoporosis.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25876051     DOI: 10.1007/s00393-015-1582-5

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN: 0340-1855            Impact factor:   1.372


  30 in total

1.  Polymorphisms in the macrophage migration inhibitory factor gene and bone loss in postmenopausal women.

Authors:  Maria Swanberg; Fiona McGuigan; Kaisa K Ivaska; Paul Gerdhem; Ulf H Lerner; Richard Bucala; George Kuchel; Anne Kenny; Kristina Akesson
Journal:  Bone       Date:  2010-05-12       Impact factor: 4.398

Review 2.  Etiopathogenesis of Behcet's disease.

Authors:  Claudia Mendoza-Pinto; Mario García-Carrasco; Mario Jiménez-Hernández; Cesar Jiménez Hernández; Carlos Riebeling-Navarro; Arnulfo Nava Zavala; Mauricio Vera Recabarren; Gerard Espinosa; Javier Jara Quezada; Ricard Cervera
Journal:  Autoimmun Rev       Date:  2009-10-30       Impact factor: 9.754

3.  [Activation of osteoclasts by RAAS and strategy of target therapy on bone metabolic diseases].

Authors:  Hideo Shimizu; Hironori Nakagami; Ryuichi Morishita
Journal:  Nihon Rinsho       Date:  2012-09

4.  Association of the osteoprotegerin gene polymorphisms with bone mineral density in postmenopausal women.

Authors:  Barbara Arko; Janez Prezelj; Andreja Kocijancic; Radovan Komel; Janja Marc
Journal:  Maturitas       Date:  2005-07-16       Impact factor: 4.342

5.  The influence of family history of hip fracture on the risk of vertebral deformity in men and women: the European Vertebral Osteoporosis Study.

Authors:  M N Diaz; T W O'Neill; A J Silman
Journal:  Bone       Date:  1997-02       Impact factor: 4.398

Review 6.  Proinflammatory actions of angiotensins.

Authors:  M Ruiz-Ortega; O Lorenzo; Y Suzuki; M Rupérez; J Egido
Journal:  Curr Opin Nephrol Hypertens       Date:  2001-05       Impact factor: 2.894

7.  Prevalence of angiotensin-converting enzyme gene insertion-deletion polymorphism in patients with primary knee osteoarthritis.

Authors:  D K Shehab; K F Al-Jarallah; A M Alawadhi; A Al-Herz; I Nahar; M Z Haider
Journal:  Clin Exp Rheumatol       Date:  2008 Mar-Apr       Impact factor: 4.473

8.  Family history of osteoporosis and bone mineral density at the axial skeleton: the Rancho Bernardo Study.

Authors:  S B Soroko; E Barrett-Connor; S L Edelstein; D Kritz-Silverstein
Journal:  J Bone Miner Res       Date:  1994-06       Impact factor: 6.741

9.  Sex-specific association of the glucocorticoid receptor gene with extreme BMD.

Authors:  Yu-Mei Peng; Shu-Feng Lei; Yan Guo; Dong-Hai Xiong; Han Yan; Liang Wang; Yan-Fang Guo; Hong-Wen Deng
Journal:  J Bone Miner Res       Date:  2008-02       Impact factor: 6.741

10.  MTHFR gene C677T mutation and ACE gene I/D polymorphism in Turkish patients with osteoarthritis.

Authors:  Ahmet Inanir; Serbulent Yigit; Sengul Tural; Osman Cecen; Eren Yildirim
Journal:  Dis Markers       Date:  2013       Impact factor: 3.434

View more
  3 in total

1.  Long-term use of angiotensin-converting enzyme inhibitors protects against bone loss in African-American elderly men.

Authors:  Nahid Rianon; Catherine G Ambrose; Hannah Pervin; Melissa Garcia; Scherezade K Mama; Ann V Schwartz; Brendan Lee; Tamara Harris
Journal:  Arch Osteoporos       Date:  2017-10-28       Impact factor: 2.617

2.  Relationship among angiotensin-converting enzyme polymorphism, cardiovascular risk, and osteoporotic fractures.

Authors:  Laisa Socorro Briongos-Figuero; Francisca Cuadrado-Medina; Laura Abad-Manteca; Gemma Vega-Tejedor; Mónica Pineda-Alonso; José Luis Pérez-Castrillón
Journal:  Eur J Rheumatol       Date:  2016-01-29

3.  Genetic Scores of eNOS, ACE and VEGFA Genes Are Predictive of Endothelial Dysfunction Associated Osteoporosis in Postmenopausal Women.

Authors:  Puneetpal Singh; Monica Singh; Rubanpal Khinda; Srishti Valecha; Nitin Kumar; Surinderpal Singh; Pawan K Juneja; Taranpal Kaur; Sarabjit Mastana
Journal:  Int J Environ Res Public Health       Date:  2021-01-22       Impact factor: 3.390

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.